Eco Animal Health Group PLC Animal Health Innovation Summit
08 March 2023 - 6:05PM
RNS Non-Regulatory
TIDMEAH
Eco Animal Health Group PLC
08 March 2023
ECO Animal Health Group plc
("ECO" or "the Group ")
(AIM: EAH)
Animal Health, Nutrition & Technology Innovation
ECO Animal Health Group plc ("ECO" or "the Group"), a leader in
the development, registration and marketing of pharmaceutical
products for global animal health markets, is pleased to announce
that it will be participating at the Animal Health, Nutrition and
Technology Innovation summit and leading the round table discussion
on swine disease management.
Animal Health, Nutrition and Technology Innovation Europe is the
sector's premier innovation summit, showcasing the emerging
companies and connecting them with investors and strategic
partners. The summit engages all key participants in the value
chain so it can address the full scope of how animal health impacts
pet owners, veterinarians, and farmers today.
Please find further information on the event at
https://kisacoresearch.com/events/animal-health-europe-2023
Contacts:
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
Singer Capital Markets (Nominated Adviser
& Joint Broker)
Phil Davies
George Tzimas 020 7496 3000
Investec (Joint Broker)
Gary Clarence
Daniel Adams
Carlo Spingardi 020 7597 5970
Equity Development
Hannah Crowe
Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches,
develops and commercialises products for livestock. Our business
strategy is to generate shareholder value by achieving the maximum
sales potential from the existing product portfolio whilst
investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUBRVROUUORAR
(END) Dow Jones Newswires
March 08, 2023 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Dec 2024 to Jan 2025
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Jan 2024 to Jan 2025